These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17503125)

  • 61. Neuropsychological measures in clinical practice.
    Possa MF
    Neurol Sci; 2010 Nov; 31(Suppl 2):S219-22. PubMed ID: 20668898
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.
    Polychroniadou E; Bakirtzis C; Langdon D; Lagoudaki R; Kesidou E; Theotokis P; Tsalikakis D; Poulatsidou K; Kyriazis O; Boziki M; Papadopoulos G; Boura E; Sintila L; Hatzigeorgiou S; Ziamos C; Ioannidis P; Karacostas D; Grigoriadis N
    Mult Scler Relat Disord; 2016 Sep; 9():68-72. PubMed ID: 27645348
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Cognitive dysfunction as a hidden multiple sclerosis related symptom relevant for an expert appraisal].
    Kraus J; Lohmann H; Evers S
    Fortschr Neurol Psychiatr; 2009 Jan; 77(1):38-43. PubMed ID: 19101878
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of two brief neuropsychological batteries in people with multiple sclerosis.
    Solari A; Mancuso L; Motta A; Mendozzi L; Serrati C
    Mult Scler; 2002 Apr; 8(2):169-76. PubMed ID: 11990875
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuropsychological investigations of multiple sclerosis: a clinical perspective.
    O'Connor MG
    Clin Neurosci; 1994; 2(3-4):225-8. PubMed ID: 7749892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Magnetic resonance imaging correlates of cognitive dysfunction in patients with multiple sclerosis].
    Filippi M
    Rev Neurol; 2000 Jun 16-30; 30(12):1253-6. PubMed ID: 10935260
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dynamic Assessment of Social Cognition in Individuals with Multiple Sclerosis: A Pilot Study.
    Genova HM; Cagna CJ; Chiaravalloti ND; DeLuca J; Lengenfelder J
    J Int Neuropsychol Soc; 2016 Jan; 22(1):83-8. PubMed ID: 26592161
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
    Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The neuropsychology of multiple sclerosis: contributions of neuroimaging research.
    Wishart HA; Flashman L; Saykin AJ
    Curr Psychiatry Rep; 2001 Oct; 3(5):373-8. PubMed ID: 11559473
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Orbitofrontal dysfunction in multiple sclerosis: Iowa Gambling Task].
    García-Molina A; Rodríguez Rajo P; Vendrell Gómez P; Junqué i Plaja C; Roig-Rovira T
    Psicothema; 2008 Aug; 20(3):445-9. PubMed ID: 18674441
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cognitive dysfunction in multiple sclerosis: methods and prevalence from the GEDMA Study.
    Olazarán J; Cruz I; Benito-León J; Morales JM; Duque P; Rivera-Navarro J
    Eur Neurol; 2009; 61(2):87-93. PubMed ID: 19039226
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PASAT in detecting cognitive impairment in relapsing-remitting MS.
    Rosti E; Hämäläinen P; Koivisto K; Hokkanen L
    Appl Neuropsychol; 2007; 14(2):101-12. PubMed ID: 17523884
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cognition in multiple sclerosis.
    Langdon DW
    Curr Opin Neurol; 2011 Jun; 24(3):244-9. PubMed ID: 21519256
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Complex evaluation of neuropsychological cognitive and emotional personality disorders in multiple sclerosis].
    Alekseeva TG; Enikolopova EV; Sadal'skaia EV; Enikolopov SN; Nanian SB; Razhba IuL; Vandysh-Bubko VV; Sidorenko VV; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; Suppl():20-5. PubMed ID: 12418388
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Cognitive impairment].
    Reuter F; Audoin B; Rico A; Malikova I; Ranjeva JP; Pelletier J
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Validity of the California Verbal Learning Test-II in multiple sclerosis.
    Stegen S; Stepanov I; Cookfair D; Schwartz E; Hojnacki D; Weinstock-Guttman B; Benedict RH
    Clin Neuropsychol; 2010 Feb; 24(2):189-202. PubMed ID: 19953426
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neuropsychological aspects of childhood multiple sclerosis: an overview.
    Blaschek A; Storm van's Gravesande K; Heinen F; Pritsch M; Mall V; Calabrese P
    Neuropediatrics; 2012 Aug; 43(4):176-83. PubMed ID: 22605613
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regression-based norms improve the sensitivity of the National MS Society Consensus Neuropsychological Battery for Pediatric Multiple Sclerosis (NBPMS).
    Smerbeck AM; Parrish J; Yeh EA; Weinstock-Guttman B; Hoogs M; Serafin D; Krupp L; Benedict RH
    Clin Neuropsychol; 2012; 26(6):985-1002. PubMed ID: 22849345
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cognitive impairment, clinic forms and progression in multiple sclerosis.
    Landete L; Casanova B
    Rev Neurol; 2001 May 1-15; 32(9):884-7. PubMed ID: 12803205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.